Table 3.
Pre-intervention concentrations of parent compounds in hand wipes and urinary metabolites
| Mothers (n = 32) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Percentiles | |||||||||
| MDLa | G Mean | G Std dev | # <MDL | % <MDL | 25th | 50th | 75th | Max | |
| Hand wipes | |||||||||
| TCEP (ng) | 2.70 | 29.17 | 2.14 | – | – | 15.65 | 30.2 | 57.93 | 111.84 |
| TCIPP (ng) | 19.80 | 224.83 | 2.63 | – | – | 103.06 | 218.91 | 466.77 | 2969.79 |
| TDCIPP (ng) | 3.90 | 133.75 | 2.63 | – | – | 76.41 | 127.34 | 244.37 | 1557.57 |
| TPHP (ng) | 1.10 | 167.82 | 3.82 | – | – | 76.71 | 131.42 | 252.59 | 4965.36 |
| ΣAlt-BFRs (ng) | 0.17 | 47.52 | 2.82 | – | – | 21.675 | 33.735 | 96.31 | 440.33 |
| ΣBDEs (ng) | 0.14 | 38.74 | 2.47 | – | – | 20.465 | 33.42 | 60.985 | 330.33 |
| BDE 209 (ng) | 0.12 | 11.75 | 2.50 | – | – | 6.345 | 11.21 | 21.915 | 73.56 |
| Urine samples | |||||||||
| BCIPP (ng/mL) | 0.15 | 0.82 | 3.31 | 4 | 12.5 | 0.36 | 0.76 | 1.93 | 11.57 |
| DPHP (ng/mL) | 0.45 | 3.34 | 2.48 | – | – | 1.90 | 2.76 | 4.45 | 39.75 |
| BDCIPP (ng/mL) | 0.19 | 1.06 | 2.41 | – | – | 0.65 | 1.11 | 2.04 | 7.77 |
| BCIPHIPP (ng/mL) | 0.64 | 1.27 | 2.22 | 1 | 3.1 | 0.75 | 1.35 | 2.18 | 6.89 |
| ip-DPHP (ng/mL) | 0.08 | 6.92 | 2.16 | – | – | 4.72 | 7.77 | 10.72 | 33.05 |
| tbutyl-DPHP (ng/mL) | 0.08 | 0.22 | 1.94 | 1 | 3.1 | 0.15 | 0.22 | 0.33 | 1.24 |
aThe reported MDL for composite measures (TBB + TBPH and ΣBDEs) is the lowest MDL of the sum